JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141999

Temsirolimus (CCI779), mTORC1 complex inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 1030.3 Da, Purity >98%. Selective mTORC1 complex inhibitor (IC50 = 1.76 µM). Water-soluble rapamycin (ab120224) pro-drug. Rapidly converts to rapamycin *in vivo*. Inhibits proliferation and angiogenesis and induces apoptosis and autophagy *in vivo*.
1 Images
Chemical Structure - Temsirolimus (CCI779), mTORC1 complex inhibitor (AB141999)
  • Chemical Structure

Lab

Chemical Structure - Temsirolimus (CCI779), mTORC1 complex inhibitor (AB141999)

2D chemical structure image of ab141999, Temsirolimus (CCI779), mTORC1 complex inhibitor

Key facts

CAS number

162635-04-3

Purity

>98%

Form

Solid

form

Molecular weight

1030.3 Da

Molecular formula

C<sub>5</sub><sub>6</sub>H<sub>8</sub><sub>7</sub>NO<sub>1</sub><sub>6</sub>

PubChem

6918289

Nature

Synthetic

Solubility

Soluble in ethanol to 100 mM

Soluble in DMSO to 100 mM

Biochemical name

Temsirolimus

Biological description

Selective mTORC1 complex inhibitor (IC50 = 1.76 µM). Water-soluble rapamycin (ab120224) pro-drug. Rapidly converts to rapamycin *in vivo*. Inhibits proliferation and angiogenesis and induces apoptosis and autophagy *in vivo*.

Canonical smiles

CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC

Isomeric smiles

C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC

InChi

InChI=1S/C56H87NO16/c1-33-17-13-12-14-18-34(2)45(68-9)29-41-22-20-39(7)56(67,73-41)51(63)52(64)57-24-16-15-19-42(57)53(65)71-46(30-43(60)35(3)26-38(6)49(62)50(70-11)48(61)37(5)25-33)36(4)27-40-21-23-44(47(28-40)69-10)72-54(66)55(8,31-58)32-59/h12-14,17-18,26,33,35-37,39-42,44-47,49-50,58-59,62,67H,15-16,19-25,27-32H2,1-11H3/b14-12+,17-13+,34-18+,38-26+/t33-,35-,36-,37-,39-,40+,41+,42+,44-,45+,46+,47-,49-,50+,56-/m1/s1

InChiKey

CBPNZQVSJQDFBE-FUXHJELOSA-N

IUPAC Name

[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Cancer science 111:1607-1618 PubMed32232883

2020

Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Kazuki Kuroshima,Hirofumi Yoshino,Shunsuke Okamura,Masafumi Tsuruda,Yoichi Osako,Takashi Sakaguchi,Satoshi Sugita,Shuichi Tatarano,Masayuki Nakagawa,Hideki Enokida

Cancer cell international 16:36 PubMed27158244

2016

Temozolomide promotes genomic and phenotypic changes in glioblastoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Aleksei A Stepanenko,Svitlana V Andreieva,Kateryna V Korets,Dmytro O Mykytenko,Vladimir P Baklaushev,Nataliya L Huleyuk,Oksana A Kovalova,Kateryna V Kotsarenko,Vladimir P Chekhonin,Yegor S Vassetzky,Stanislav S Avdieiev,Vladimir V Dmitrenko
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com